Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.3600 (0.27%) ($7.3600 - $7.3600) on Mon. Sep. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 57 | Latest Price | $7.3600(0.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VIXM(98%) XOP(37%) VXX(25%) TBT(31%) UUP(23%) | Factors Impacting BCRX price | BCRX will decline at least -1.64% in a week (0% probabilities). ICLN(-47%) IFRA(-35%) IDRV(49%) IWD(-28%) KWEB(37%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.33(0.41%) | 10 Day Moving Average | $7.2(2.22%) | 20 Day Moving Average | $7.13(3.23%) | To recent high | -6.7% | To recent low | 9.9% | Market Cap | $1.299b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |